Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 MutationsDavid M. Hyman, José Baselga, Ian Chau et al.|New England Journal of Medicine|2015Cited by 1.7k
KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated AnalysisMarc Peeters, Scott D. Patterson, Kelly S. Oliner et al.|Annals of Oncology|2014Cited by 3